Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Childs

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Immunotherapy for renal cell cancerJames C Yang, Richard Childs
Seminars in Hematology|October 30, 2016
Haploidentical cord transplantation-The best of both worldsKoen van Besien, Richard Childs
Seminars in Oncology|February 19, 2004
Allogeneic stem cell transplantation as immunotherapy for nonhematological cancersRam Srinivasan, John Barrett, Richard Childs
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2011
Giant duodenal ectasiaDouglas H Weinstein, Richard Childs, Theo Heller
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2009
Cutting edge: bortezomib-treated tumors sensitized to NK cell apoptosis paradoxically acquire resistance to antigen-specific T cellsAndreas Lundqvist, Su Su, Sheila Rao, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2014
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivoErik Wennerberg, Veronika Kremer, Richard Childs, et al.
Blood|October 16, 2010
Toxic effects of sorafenib when given early after allogeneic hematopoietic stem cell transplantationHisayuki Yokoyama, Andreas Lundqvist, Su Su, et al.
Blood|December 21, 2006
Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donorsAndreas Lundqvist, J Philip McCoy, Leigh Samsel, et al.
Experimental Hematology|April 23, 2004
Green fluorescent protein expression in dendritic cells enhances their immunogenicity and elicits specific cytotoxic T-cell responses in humansFrancesca Re, Ramaprasad Srinivasan, Takehito Igarashi, et al.
Blood|February 10, 2009
Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cellsAndreas Lundqvist, Hisayuki Yokoyama, Aleah Smith, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Immunotherapy for renal cell cancerJames C Yang, Richard Childs
Seminars in Hematology|October 30, 2016
Haploidentical cord transplantation-The best of both worldsKoen van Besien, Richard Childs
Seminars in Oncology|February 19, 2004
Allogeneic stem cell transplantation as immunotherapy for nonhematological cancersRam Srinivasan, John Barrett, Richard Childs
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2011
Giant duodenal ectasiaDouglas H Weinstein, Richard Childs, Theo Heller
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2009
Cutting edge: bortezomib-treated tumors sensitized to NK cell apoptosis paradoxically acquire resistance to antigen-specific T cellsAndreas Lundqvist, Su Su, Sheila Rao, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2014
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivoErik Wennerberg, Veronika Kremer, Richard Childs, et al.
Blood|October 16, 2010
Toxic effects of sorafenib when given early after allogeneic hematopoietic stem cell transplantationHisayuki Yokoyama, Andreas Lundqvist, Su Su, et al.
Blood|December 21, 2006
Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donorsAndreas Lundqvist, J Philip McCoy, Leigh Samsel, et al.
Experimental Hematology|April 23, 2004
Green fluorescent protein expression in dendritic cells enhances their immunogenicity and elicits specific cytotoxic T-cell responses in humansFrancesca Re, Ramaprasad Srinivasan, Takehito Igarashi, et al.
Blood|February 10, 2009
Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cellsAndreas Lundqvist, Hisayuki Yokoyama, Aleah Smith, et al.
Pageof 9